| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.049 | 0.4 |